Furthermore, CD10+GPR77+ CAFs promote successful engraftment of PDXs, and targeting these CAFs with a neutralizing anti-GPR77 antibody abolishes tumor formation and restores tumor chemosensitivity via the production of IL-6 and IL-8 [72]. This evidence concerns the gene C5AR2 and neoplasm.